Trevi Therapeutics, Inc. Logo

Trevi Therapeutics, Inc.

Clinical-stage biopharma developing an oral therapy for chronic cough in IPF and RCC.

TRVI | US

Overview

Corporate Details

ISIN(s):
US89532M1018
LEI:
Country:
United States of America
Address:
195 CHURCH STREET, 6510 NEW HAVEN
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing its investigational therapy, Haduvio™ (oral nalbuphine ER). The company's primary focus is addressing chronic cough in patients with conditions such as idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC). Haduvio is a dual-mechanism therapy that acts as a kappa opioid receptor agonist and a mu opioid receptor antagonist, targeting the cough reflex arc both centrally and peripherally. Trevi aims to address a significant unmet medical need, as there are currently no approved therapies in the U.S. for these debilitating conditions. The company has announced positive results from its Phase 2 clinical trials, demonstrating a statistically significant reduction in cough frequency.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Trevi Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Trevi Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Trevi Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
SEYFERT LTD. Logo
Provides recruitment, staffing, and education services for the beauty salon industry.
Japan 9213
SG Company Logo
A consulting firm for 360° communication, marketing, and event services for businesses.
Italy SGC
SHIKIGAKU.Co.,Ltd. Logo
Drives organizational growth with a unique management theory for diverse corporate clients.
Japan 7049
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. Logo
A contract research organization providing preclinical and clinical services for medical industries.
Japan 2395
A healthcare support company for medical facilities, offering consulting, equipment, and supplies.
Japan 3360
Silence Therapeutics plc Logo
Develops RNAi therapies that silence disease genes for rare and underserved conditions.
United States of America SLN
SillaTextile Logo
Italian consultancy for fabric design and development for high-end apparel brands.
South Korea 001000
Simulations Plus, Inc. Logo
Modeling & simulation software and consulting for pharma/biotech to accelerate drug development.
United States of America SLP
Skeena Resources Ltd Logo
Revitalizing past-producing mines for gold, silver, and critical metals in BC's Golden Triangle.
United States of America SKE
SLSBio(Specialty Lab Solution Bio) Co., Ltd Logo
Provides pharma lab services, clinical trial analysis, and innovative diagnostic products.
South Korea 246250

Talk to a Data Expert

Have a question? We'll get back to you promptly.